Cleared Abbreviated

TELZUIT CARDIAC MONITORING SYSTEM (K031229) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K031229 · Telzuit Technologies, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2003
Decision
82d
Days
Class 2
Risk

K031229 is an FDA 510(k) clearance for the TELZUIT CARDIAC MONITORING SYSTEM. Classified as Transmitters And Receivers, Electrocardiograph, Telephone (product code DXH), Class II - Special Controls.

Submitted by Telzuit Technologies, Inc. (North Attleboro, US). The FDA issued a Cleared decision on July 9, 2003 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2920 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Telzuit Technologies, Inc. devices

Submission Details

510(k) Number K031229 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 2003
Decision Date July 09, 2003
Days to Decision 82 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 125d · This submission: 82d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DXH Transmitters And Receivers, Electrocardiograph, Telephone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXH Transmitters And Receivers, Electrocardiograph, Telephone

All 54
Devices cleared under the same product code (DXH) and FDA review panel - the closest regulatory comparables to K031229.
FibriCheck
K173872 · Qompium NV · Sep 2018
CARDIOSKIN
K173248 · Bioserenity Sas · Aug 2018
QT ECG
K180157 · QT Medical, Inc. · May 2018
MODIFIED MEMORYTRACE ER MODEL 4221 ECG MONITOR
K915769 · Medtronic Vascular · Jan 1992
MODEL M1403A TELEMETRY MONITORING SYSTEMS (TMS)
K913533 · Hewlett-Packard Co. · Nov 1991
MEDTRONIC CARDIOCARE MEMORYTRACE ER MODEL 4221
K912084 · Medtronic Vascular · Jul 1991